Published in Transplantation on November 15, 2002
Long-term consequences of kidney donation. N Engl J Med (2009) 10.17
The state of U.S. living kidney donors. Clin J Am Soc Nephrol (2010) 2.11
Substantial variation in the acceptance of medically complex live kidney donors across US renal transplant centers. Am J Transplant (2008) 1.57
Health insurance status of US living kidney donors. Clin J Am Soc Nephrol (2010) 1.16
Utility of the Japanese GFR estimation equation for evaluating potential donor kidney function. Clin Exp Nephrol (2009) 1.03
Outcomes of living kidney donors with medullary sponge kidney. Clin Kidney J (2015) 0.98
Kidney transplant outcomes for prior living organ donors. J Am Soc Nephrol (2014) 0.96
Living related small bowel transplantation: donor surgical technique. Ann Surg (2004) 0.88
Renal agenesis and unilateral nephrectomy: what are the risks of living with a single kidney? Pediatr Nephrol (2008) 0.85
Medical follow-up of living kidney donors by 1 year after nephrectomy. Transplant Proc (2009) 0.80
Renal transplantation from elderly living donors. J Transplant (2013) 0.79
Comparison of the laparoscopic versus open live donor nephrectomy: an overview of surgical complications and outcome. Langenbecks Arch Surg (2014) 0.78
Live kidney donation: are concerns about long-term safety justified?-A methodological review. Eur J Epidemiol (2016) 0.78
Evaluation of the medically complex living kidney donor. J Transplant (2012) 0.77
A higher glomerular filtration rate predicts low risk of developing chronic kidney disease in living kidney donors. World J Surg (2013) 0.76
LOng-term follow-up after liVE kidney donation (LOVE) study: a longitudinal comparison study protocol. BMC Nephrol (2016) 0.75
Monoclonal gammopathy of undetermined significance: a contraindication for living kidney donation? NDT Plus (2011) 0.75
Single-centre long-term follow-up of live kidney donors demonstrates preserved kidney function but the necessity of a structured lifelong follow-up. Ups J Med Sci (2014) 0.75
Long-term renal function, complications and life expectancy in living kidney donors. World J Transplant (2012) 0.75
Change in renal function following laparoscopic donor nephrectomy using 99 mTc-diethylenetriaminepentaacetic acid scan. World J Urol (2014) 0.75
Living-donor kidney transplantation: the Freiburg experience. Langenbecks Arch Surg (2006) 0.75
Outcomes of Kidney Donors over 60 Years Old: A Single-Center Cohort Study. World J Surg (2017) 0.75
Perioperative mortality and long-term survival following live kidney donation. JAMA (2010) 7.34
Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med (2006) 5.42
Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation (2002) 3.42
Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA (2003) 3.33
The ethics statement of the Vancouver Forum on the live lung, liver, pancreas, and intestine donor. Transplantation (2006) 3.24
Morbidity and mortality after living kidney donation, 1999-2001: survey of United States transplant centers. Am J Transplant (2003) 2.95
Case records of the Massachusetts General Hospital. Case 15-2009. A 25-year-old man with coma after cardiac arrest. N Engl J Med (2009) 2.65
A report of the Vancouver Forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines. Transplantation (2006) 2.55
Laparoscopic live donor nephrectomy: a risk factor for delayed function and rejection in pediatric kidney recipients? A UNOS analysis. Am J Transplant (2005) 2.29
Expanded criteria donors for kidney transplantation. Am J Transplant (2003) 2.25
Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int (2002) 2.10
Estimates of early death, acute liver failure, and long-term mortality among live liver donors. Gastroenterology (2011) 2.07
National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant (2004) 2.01
Living-donor kidney transplantation: a review of the current practices for the live donor. J Am Soc Nephrol (2005) 1.93
Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant (2002) 1.92
Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. Transplantation (2003) 1.88
Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol (2002) 1.84
Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol (2008) 1.76
Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation (2002) 1.75
Donation after cardiac death as a strategy to increase deceased donor liver availability. Ann Surg (2006) 1.66
The rationale for the new deceased donor pancreas allocation schema. Transplantation (2007) 1.58
Aggressive pharmacologic donor management results in more transplanted organs. Transplantation (2003) 1.45
Trends over a decade of pediatric liver transplantation in the United States. Liver Transpl (2006) 1.45
Post-transplant de novo malignancies in renal transplant recipients: the past and present. Transpl Int (2006) 1.45
Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant (2002) 1.44
The consequences of public policy to buy and sell organs for transplantation. Am J Transplant (2004) 1.43
A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation. Transplantation (2003) 1.41
Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients. Liver Transpl (2009) 1.29
Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysis. Transpl Int (2010) 1.25
Early mortality rates in older kidney recipients with comorbid risk factors. Transplantation (2007) 1.22
Transplant tumor registry: donor related malignancies. Transplantation (2002) 1.19
A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation (2003) 1.19
Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA. Liver Transpl (2004) 1.19
Hormonal resuscitation yields more transplanted hearts, with improved early function. Transplantation (2003) 1.18
Hormonal therapy of the brain-dead organ donor: experimental and clinical studies. Transplantation (2006) 1.17
Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation. Transpl Int (2005) 1.17
The report of a national conference on the wait list for kidney transplantation. Am J Transplant (2003) 1.14
Impact of the expanded criteria donor allocation system on the use of expanded criteria donor kidneys. Transplantation (2005) 1.10
Analysis of the wait list and deaths among candidates waiting for a kidney transplant. Transplantation (2008) 1.10
Quality control of the OPTN/UNOS Transplant Registry. Transplantation (2004) 1.03
Organ donation and utilization in the USA. Am J Transplant (2004) 1.03
Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy. Am J Transplant (2003) 1.03
Organ trafficking and transplant tourism: the role of global professional ethical standards-the 2008 Declaration of Istanbul. Transplantation (2013) 1.03
The role of procurement biopsies in acceptance decisions for kidneys retrieved for transplant. Clin J Am Soc Nephrol (2014) 1.02
Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis. Kidney Int (2004) 1.01
Financial incentives for cadaver organ donation: an ethical reappraisal. Transplantation (2002) 1.00
A report of the Lisbon Conference on the care of the kidney transplant recipient. Transplantation (2007) 0.97
The critical pathway for deceased donation: reportable uniformity in the approach to deceased donation. Transpl Int (2011) 0.96
Transplantation in the diabetic patient with advanced chronic kidney disease: a task force report. Am J Kidney Dis (2004) 0.95
Increasing the supply of kidneys for transplantation. Semin Dial (2006) 0.94
Transplant tumor registry: donors with central nervous system tumors1. Transplantation (2002) 0.93
Utilization of extended donor criteria liver allograft: Is the elevated risk of failure independent of the model for end-stage liver disease score of the recipient? Transplantation (2006) 0.92
An analysis of the lack of donor pancreas utilization from younger adult organ donors. Transplantation (2010) 0.92
The nondirected live-kidney donor: ethical considerations and practice guidelines: A National Conference Report. Transplantation (2002) 0.90
Improving institutional fairness to live kidney donors: donor needs must be addressed by safeguarding donation risks and compensating donation costs. Transpl Int (2007) 0.89
Statement of the Declaration of Istanbul Custodian Group Regarding Payments to Families of Deceased Organ Donors. Transplantation (2016) 0.89
Deceased donors with a past history of malignancy: an organ procurement and transplantation network/united network for organ sharing update. Transplantation (2007) 0.88
Pretransplant recipient cytomegalovirus seropositivity and hemodialysis are associated with decreased renal allograft and patient survival. Transplantation (2004) 0.88
Evolution of endpoints for renal transplant outcome. Am J Transplant (2003) 0.86
Skin cancer in organ transplant recipients: effect of pretransplant end-organ disease. J Am Acad Dermatol (2005) 0.86
Survival of mandatorily shared cadaveric kidneys and their paybacks in the zero mismatch era. Transplantation (2002) 0.85
Kidney transplantation after previous liver transplantation: analysis of the organ procurement transplant network database. Transplantation (2011) 0.85
Reasons for non-use of recovered kidneys: the effect of donor glomerulosclerosis and creatinine clearance on graft survival. Transplantation (2004) 0.84
The prohibition of kidney sales and organ markets should remain. Curr Opin Organ Transplant (2008) 0.84
The development of a successful multiregional kidney paired donation program. Transplantation (2008) 0.83
Increasing the opportunity of live kidney donation by matching for two- and three-way exchanges. Transplantation (2006) 0.83
When organ donors are still patients: is premortem use of heparin ethically acceptable? Am J Crit Care (2007) 0.83
Global initiatives to tackle organ trafficking and transplant tourism. Med Health Care Philos (2013) 0.83
Prevention of Transnational Transplant-Related Crimes-What More Can be Done? Transplantation (2016) 0.82
Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation. Transplantation (2002) 0.82
Posttransplantation malignancies: a problem, a challenge, and an opportunity. Liver Transpl (2002) 0.82
Organ donation and dual advocacy. N Engl J Med (2008) 0.82
South East European Health Network Initiative for Organ Donation and Transplantation. Transplantation (2015) 0.80
Research to practice: a national consensus conference. Prog Transplant (2005) 0.80
Vancouver forum on the live lung, liver, pancreas, and intestine donor. Transplantation (2006) 0.80
The development of the Declaration of Istanbul on Organ Trafficking and Transplant Tourism. Nephrol Dial Transplant (2008) 0.80
Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction. Clin Transplant (2004) 0.78
Long-term outcome of a cuffed expanded PTFE graft for hemodialysis vascular access. World J Surg (2008) 0.78
Successful Recovery and Transplantation of 11 Organs Including Face, Bilateral Upper Extremities, and Thoracic and Abdominal Organs From a Single Deceased Organ Donor. Transplantation (2016) 0.78
The OPTN waiting list, 1988-2002. Clin Transpl (2003) 0.77
Allograft and overall survival of patients with posttransplant skin cancer. Dermatol Surg (2011) 0.77
Human T-cell lymphotrophic virus type-1 and organ donors. Transplantation (2003) 0.77
Changing Patterns of Organ Donation: Brain Dead Donors Are Not Being Lost by Donation After Circulatory Death. Transplantation (2016) 0.77
Assessing organ donation from the dead should not be done by reporting a census of the living. Am J Transplant (2003) 0.77
Pediatric Deceased Donation-A Report of the Transplantation Society Meeting in Geneva. Transplantation (2015) 0.77
A colloquium on the congress "A gift for life. Considerations on organ donation". Transplantation (2009) 0.76